Researchers treat brain cancer patient with skin cancer drug Researchers at Memorial Sloan Kettering Cancer Center (MSK) are exploring a new form of clinical trial called a basket trial, which is designed to examine responses to drugs based on specific mutations in patients’ tumors rather than where their cancer originated.
Tackling prostate cancer: NFL Hall-of-Famer urges men to 'Know Your Stats' The NFL and the Urology Care Foundation are teaming up for the Know Your Stats campaign – an initiative to raise awareness and encourage men to know their prostate cancer risk – with a PSA that will air during Super Bowl XLVIII
People want radiology reports, discussions with docs Most patients want to receive imaging results directly from the doctor who sent them for scans, but many also want to see their radiology reports, a survey finds.
VBL Therapeutics' brain cancer drug succeeds in mid-stage study Israel-based VBL Therapeutics said a mid-stage study of its experimental brain cancer drug met the main goal of increasing overall survival.
Bald and strong: Nonprofit raises cancer awareness, challenges vanity Showing support for cancer comes in many forms— but would you go bald for it? That’s the challenge issued by Be Bold, Be Bald!, a campaign by non-profit Small Army for a Cause.
Quest Diagnostics, French agency seek to expand breast cancer gene database Quest Diagnostics Inc, the world's largest provider of diagnostic testing services, is working with France's national health agency to build an expanded database for BRCA1 and BRCA2 gene mutations to better determine patient hereditary risks of breast and ovarian cancer.
Some indoor tanning locations may attract 'high-risk' tanners People who go tanning at gyms or beauty shops may have riskier tanning habits than those who go to tanning salons, new research finds
Study supports watch-and-wait approach for many prostate cancers In a long-term study of older men diagnosed with low-risk prostate cancer and followed with so-called active surveillance, less than a third of cases eventually needed treatment, according to a new study.
Genetic counseling is rare among BRCA-tested women Although counseling is widely recommended before gene testing, most U.S. women who were sent by doctors to be tested for BRCA1 and BRCA2, two genes that increase the risk of breast and ovarian cancer, never met with a counselor beforehand.
US strengthens rules to protect farm workers from pesticides An estimated 2 million U.S. farm workers, children and others who work or live near farm fields will have more protection from hazardous pesticides under changes unveiled Monday by federal officials.
